Deferred Tax Assets, Valuation Allowance in USD of Regen BioPharma Inc from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Regen BioPharma Inc quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q1 2014 to Q3 2024.
  • Regen BioPharma Inc Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Sep 2024 was $4.29M, a 3.38% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Regen BioPharma Inc Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2024 $4.29M +$140K +3.38% 30 Sep 2024 10-K 13 May 2025
Q3 2023 $4.15M -$243K -5.53% 30 Sep 2023 10-K 13 May 2025
Q3 2022 $4.39M -$513K -10.5% 30 Sep 2022 10-K 15 Nov 2022
Q3 2021 $4.9M +$1.42M +40.8% 30 Sep 2021 10-K 22 Dec 2021
Q3 2020 $3.48M -$717K -17.1% 30 Sep 2020 10-K 04 Aug 2021
Q3 2019 $4.2M +$534K +14.6% 30 Sep 2019 10-K 21 Jun 2021
Q4 2018 $3.6M -$1.68M -31.9% 31 Dec 2018 10-Q 12 Feb 2019
Q3 2018 $3.67M -$666K -15.4% 30 Sep 2018 10-K 27 Dec 2018
Q2 2018 $3.46M -$445K -11.4% 30 Jun 2018 10-Q 06 Aug 2018
Q1 2018 $3.5M +$483K +16% 31 Mar 2018 10-Q 14 May 2018
Q4 2017 $5.28M -$2.46M -31.7% 31 Dec 2017 10-Q 06 Feb 2018
Q3 2017 $4.33M -$2.54M -37% 30 Sep 2017 10-K 05 Jan 2018
Q2 2017 $3.91M -$2.14M -35.4% 30 Jun 2017 10-Q 07 Aug 2017
Q1 2017 $3.02M -$2.23M -42.5% 31 Mar 2017 10-Q 05 May 2017
Q4 2016 $7.73M +$2.86M +58.7% 31 Dec 2016 10-Q/A 28 Apr 2017
Q3 2016 $6.88M +$2.64M +62.1% 30 Sep 2016 10-K/A 28 Apr 2017
Q2 2016 $6.04M +$2.01M +49.7% 30 Jun 2016 10-Q/A 28 Apr 2017
Q1 2016 $5.24M +$1.74M +49.6% 31 Mar 2016 10-Q/A 28 Apr 2017
Q4 2015 $4.87M +$5.38M 31 Dec 2015 10-Q/A 28 Apr 2017
Q3 2015 $4.24M +$4.68M 30 Sep 2015 10-K/A 28 Apr 2017
Q2 2015 $4.04M +$4.41M 30 Jun 2015 10-Q/A 28 Apr 2017
Q1 2015 $3.51M +$3.82M 31 Mar 2015 10-Q/A 28 Apr 2017
Q4 2014 -$509K 31 Dec 2014 10-Q 04 Feb 2015
Q3 2014 -$435K 30 Sep 2014 10-K 18 Dec 2014
Q2 2014 -$369K 30 Jun 2014 10-Q 07 Aug 2014
Q1 2014 -$312K 31 Mar 2014 10-Q 05 May 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.